| Bioactivity | Somatostatin-25 is a endogenous neuropeptide hormone that shows inhibitory activity against secretion of growth hormone. |
| Invitro | Somatostatin-25 (0.1 pM-1 nM) significantly inhibits secretion of growth hormone in the in vitro system, and is 3-14 times more effective than the tetradecapeptide. Somatostatin-25 (0.1 nM-1pM) also inhibits secretion of growth hormone induced by the addition of prostaglandin 2 (PGE2). However, Somatostatin-25 shows no effect on the secretion of prolactin[1]. |
| Name | Somatostatin-25 |
| CAS | 76461-17-1 |
| Sequence | Ser-Asn-Pro-Ala-Met-Ala-Pro-Arg-Glu-Arg-Lys-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys (Disulfide bridge: Cys14-Cys25) |
| Shortening | SNPAMAPRERKAGCKNFFWKTFTSC (Disulfide bridge: Cys14-Cys25) |
| Formula | C127H191N37O34S3 |
| Molar Mass | 2876.30 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Somatostatin-25
CAS: 76461-17-1 F: C127H191N37O34S3 W: 2876.30
Somatostatin-25 is a endogenous neuropeptide hormone that shows inhibitory activity against secretion of growth hormone.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.